Loading company
MiniMed Group, Inc.
MMED · Nasdaq · ·
$20.06-2.1%Sep 29 close
- 1M
- -0.2%
- 6M
- +39.8%
MMED · Nasdaq · ·
$20.06-2.1%Sep 29 close
The quarter ending July 31, 2026, against the same quarter a year earlier.
| Measure | 3 months toJul 31, 2026 | 3 months toApr 25, 2025 | Change |
|---|---|---|---|
| Total Revenue | $843M | $724M | +16.44% |
| Profit | $0.00 | -$19M | +100.00% |
| Profit per share | $0.00 | -$0.68 | +100.00% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
MiniMed Group, Inc. has no earnings call transcript available.
“MiniMed delivered an excellent start to our fiscal year, with accelerating U.S. growth, continued double-digit international growth, and strong execution across our innovation pipeline,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land after the close or before the open, so the move is the session that follows.
MiniMed is a global leader in insulin delivery, constantly advancing therapies that support people with diabetes in more than 80 countries. Our full-stack, integrated ecosystem, including our insulin delivery systems, CGMs, algorithms, and easy-to-use app experience, is designed to work seamlessly together, supported by white-glove, wrap-around service. For over 40 years, we’ve pioneered therapies people can rely on by anticipating needs, reducing burden, and helping make life with diabetes easier. Our mission is to make every day a better day for people with diabetes.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from MiniMed Group, Inc.’s Item 2.02 8-K filed September 1, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.